These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2116558)
21. 3-Hydroxy-3-methylglutaric aciduria: response to carnitine therapy and fat and leucine restriction. Dasouki M; Buchanan D; Mercer N; Gibson KM; Thoene J J Inherit Metab Dis; 1987; 10(2):142-6. PubMed ID: 2443756 [TBL] [Abstract][Full Text] [Related]
22. Inherited 3-methylglutaconic aciduria in two brothers--another defect of leucine metabolism. Duran M; Beemer FA; Tibosch AS; Bruinvis L; Ketting D; Wadman SK J Pediatr; 1982 Oct; 101(4):551-4. PubMed ID: 6181239 [TBL] [Abstract][Full Text] [Related]
23. [Glutaric aciduria type I: report of a case]. Zhong L; Yang YJ; Luo F; Sun JP; Yu XH Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):557. PubMed ID: 15324589 [No Abstract] [Full Text] [Related]
29. Subdural hematoma and glutaric aciduria type 1. Drigo P; Burlina AB; Battistella PA Brain Dev; 1993; 15(6):460-1. PubMed ID: 8147506 [No Abstract] [Full Text] [Related]
30. 3-Methylglutaconic aciduria: a common biochemical marker in various syndromes with diverse clinical features. Gunay-Aygun M Mol Genet Metab; 2005 Jan; 84(1):1-3. PubMed ID: 15719488 [No Abstract] [Full Text] [Related]
31. 3-Methylglutaconic aciduria: a new variant. Zeharia A; Elpeleg ON; Mukamel M; Weitz R; Ariel R; Mimouni M Pediatrics; 1992 Jun; 89(6 Pt 1):1080-2. PubMed ID: 1594352 [TBL] [Abstract][Full Text] [Related]
32. 3-Methylglutaconic aciduria type I redefined: a syndrome with late-onset leukoencephalopathy. Wortmann SB; Kremer BH; Graham A; Willemsen MA; Loupatty FJ; Hogg SL; Engelke UF; Kluijtmans LA; Wanders RJ; Illsinger S; Wilcken B; Cruysberg JR; Das AM; Morava E; Wevers RA Neurology; 2010 Sep; 75(12):1079-83. PubMed ID: 20855850 [TBL] [Abstract][Full Text] [Related]
34. [Inborn errors of lysine metabolism]. Divry P; Vianey-Liaud C; Mathieu M Ann Biol Clin (Paris); 1991; 49(1):27-35. PubMed ID: 1904694 [TBL] [Abstract][Full Text] [Related]
35. D-2-hydroxyglutaric aciduria: evidence of clinical and biochemical heterogeneity. Wagner L; Hoffmann GF; Jakobs C J Inherit Metab Dis; 1998 Jun; 21(3):247-50. PubMed ID: 9686368 [No Abstract] [Full Text] [Related]
36. Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid. Ostman-Smith I; Brown G; Johnson A; Land JM Br Heart J; 1994 Oct; 72(4):349-53. PubMed ID: 7833193 [TBL] [Abstract][Full Text] [Related]
37. Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation. Wortmann S; Rodenburg RJ; Huizing M; Loupatty FJ; de Koning T; Kluijtmans LA; Engelke U; Wevers R; Smeitink JA; Morava E Mol Genet Metab; 2006 May; 88(1):47-52. PubMed ID: 16527507 [TBL] [Abstract][Full Text] [Related]
38. Riboflavin responsive glutaric aciduria type II. Gregersen N; Rhead W; Christensen E Prog Clin Biol Res; 1990; 321():477-94. PubMed ID: 2183240 [No Abstract] [Full Text] [Related]
39. D-Glyceric acidemia in a patient with chronic metabolic acidosis. Wadman SK; Duran M; Ketting D; Bruinvis L; De Bree PK; Kamerling JP; Gerwig GJ; Vliegenthart JF; Przyrembel H; Becker K; Bremer HJ Clin Chim Acta; 1976 Sep; 71(3):477-84. PubMed ID: 971536 [TBL] [Abstract][Full Text] [Related]
40. Milder clinical course of Type IV 3-methylglutaconic aciduria due to a novel mutation in TMEM70. Shchelochkov OA; Li FY; Wang J; Zhan H; Towbin JA; Jefferies JL; Wong LJ; Scaglia F Mol Genet Metab; 2010; 101(2-3):282-5. PubMed ID: 20728387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]